Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ·Healthcare·Biotechnology
$0.65
-6.57%
Mkt Cap $7.72M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$0.65
-6.57%
Mkt Cap $7.72M
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —